Cravath Publishes Winter 2026 Issue of Alumni Journal
August 24, 2021
On August 24, 2021, GuideWell Mutual Holding Corporation (“GuideWell”), a health solutions company and parent of Blue Cross and Blue Shield of Florida, Inc., and Triple-S Management Corporation (“Triple-S Management”), a leading health care services company in Puerto Rico, announced they will combine. Under the terms of the definitive agreement, GuideWell will acquire all the outstanding shares of Triple-S Management common stock for $36.00 per share in cash. The transaction equity value is approximately $900 million. Upon completion of the transaction, Triple-S Management will become a subsidiary of GuideWell and will continue to operate under the Triple-S Management brand. Cravath is representing GuideWell in connection with the transaction.
The Cravath team is led by partners Minh Van Ngo and Andrew M. Wark and includes associates Douglas C. Dolan, Catriela Cohen, Andrea Román-González and Jesse P. Houchens on M&A matters; partners Jonathan J. Katz and Matthew J. Bobby, practice area attorney Aaron S. Cha and associates Tiffany B. Wong and David Crampton on executive compensation and benefits matters; partner Margaret T. Segall on antitrust matters; partner Matthew Morreale on environmental matters; practice area attorney Anthony N. Magistrale on intellectual property matters; practice area attorneys Brian M. Budnick and Laurel R. Berkowitz on real estate matters; and associates Arvind Ravichandran and Joana W. Li on tax matters. Jill C. Refvem also worked on M&A matters.
Deals & Cases
March 31, 2026
On March 31, 2026, Biogen Inc. and Apellis Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share held, entitling the holder to receive two payments of $2 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE®. Cravath is representing Biogen in connection with the transaction.
Deals & Cases
March 09, 2026
On March 9, 2026, Universal Health Services, Inc. (“UHS”) announced that it has entered into a definitive agreement to acquire Talkspace, Inc. (“Talkspace”) for $5.25 per share. The enterprise value for the transaction is approximately $835 million. Cravath is representing Talkspace in connection with the transaction.
Deals & Cases
February 18, 2026
On February 17, 2026, Tenax Aerospace Acquisition, LLC (“Tenax”) and Air Industries Group (“Air”) jointly announced that they have entered into an Agreement and Plan of Merger to combine Tenax’s special mission aviation business with Air’s precision aerospace manufacturing business. At the time of the merger, Air will issue shares of its common stock to holders of Tenax membership units. After the closing, Tenax shareholders are expected to own approximately 95% of Air’s outstanding shares while existing Air shareholders are expected to own approximately 5%, and the combined company expects to remain listed on the NYSE American under the symbol AIRI. Cravath is representing Tenax in connection with the transaction.
Deals & Cases
February 17, 2026
On February 17, 2026, Kennedy‑Wilson Holdings, Inc. (“Kennedy Wilson”) and Fairfax Financial Holdings Limited (“Fairfax”) jointly announced that Kennedy Wilson has entered into a definitive agreement to be acquired, in an all cash‑transaction, by an entity affiliated with a consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy Wilson, and certain other senior executives of Kennedy Wilson (collectively, the “KW Management Group”), together with Fairfax (collectively, the “Consortium”).
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.